May 19, 2009
Genomics researcher receives accolade for discoveries
Todd Golub, MD
Groundbreaking contributions to cancer research through the application of basic biology and genomics to the discovery of diagnostic and therapeutic cancer targets have earned Todd Golub, MD, top honors from the American Association for Cancer Research (AACR).
Golub, the Charles A. Dana investigator in human cancer genetics at Dana-Farber and founding director of the cancer program at the Broad Institute of Harvard and MIT, was been awarded the 33rd Annual AACR Richard and Hinda Rosenthal Memorial Award. Established in 1977, the Rosenthal award recognizes research that has made, or promises to make, a notable contribution to improved clinical care in the field of cancer by young investigators relatively early in their careers.
Golub is one of 10 researchers being saluted by the association, the oldest and largest professional organization representing cancer scientists, at its 100th annual meeting in Colorado this week. The AACR awards honor outstanding accomplishments in either basic cancer research, clinical research, epidemiology, therapeutics, or prevention.
"We know scientists don't work for the accolades they may receive, but to advance the progress against cancer. The AACR believes that the acknowledgement and support it provides through these awards enables researchers to get closer to better prevention, treatments, and cures for cancer," says AACR CEO Margaret Foti, MD, PhD. The award comes with a $10,000 honorarium.
Golub's work has paved the way for the development of commercial diagnostic tests to aid patients in treatment decisions. His current research, using genomics to transform the drug discovery process, has led to potential new treatments for acute myeloid leukemia, prostate cancer, and Ewing sarcoma.
"This is a tremendous honor, and I'm very pleased to accept on behalf of a committed group of Dana-Farber colleagues who represent a true team effort," says Golub.
The genomics investigator joins the ranks of several Dana-Farber researchers who have received the AACR accolade, including William Kaelin, MD, and Lee Nadler, MD
News
DF/CHCC ranks best in New England, tops in country
For the third year in a row, Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) was ranked the number one pediatric cancer program in New England, and one of the best in the country in U.S. News & World Report's 2010-2011 Best Children's Hospitals issue. read more
Upcoming Events
Join us at SIOP Boston 2010
Dana-Farber/Children's Hospital Cancer Center is proud to welcome the 42nd Congress of the International Society of Paediatric Oncology (SIOP) to Boston, October 21-24, 2010. SIOP features an exciting scientific and social agenda for all members of the pediatric oncology community, including oncologists, surgeons, radiotherapists, pathologists, nurses, basic scientists, epidemiologists, biostatisticians, psychologists, and parents and survivors. Don't miss this opportunity to interact with your the global colleagues. Visit www.siopboston2010.com and register today.
